Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia

BACKGROUND: Because of the high risk of thrombotic complications (TCs) during SARS-CoV-2 infection, several scientific societies have proposed to increase the dose of preventive anticoagulation, although arguments in favor of this strategy are inconsistent. RESEARCH QUESTION: What is the incidence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tacquard, Charles, Mansour, Alexandre, Godon, Alexandre, Godet, Julien, Poissy, Julien, Garrigue, Delphine, Kipnis, Eric, Rym Hamada, Sophie, Mertes, Paul Michel, Steib, Annick, Ulliel-Roche, Mathilde, Bouhemad, Bélaïd, Nguyen, Maxime, Reizine, Florian, Gouin-Thibault, Isabelle, Besse, Marie Charlotte, Collercandy, Nived, Mankikian, Stefan, Levy, Jerrold H., Gruel, Yves, Albaladejo, Pierre, Susen, Sophie, Godier, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:
Pulmonary and Cardiovascular: Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832130/
https://www.ncbi.nlm.nih.gov/pubmed/33465342
http://dx.doi.org/10.1016/j.chest.2021.01.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832130/
https://www.ncbi.nlm.nih.gov/pubmed/33465342
http://dx.doi.org/10.1016/j.chest.2021.01.017

Ejemplares similares